Company intelligence / Profile preview

3V SourceOne Capital

Singapore, Singapore

Ownership: Private
Employees: ~9
Development stage: Other

Overview

3V SourceOne Capital was a Singapore-based private equity and venture capital firm that specialized in growth and late-stage investments in companies with strategic links to Asian markets. Founded in 2000, the firm operated offices in Singapore and Silicon Valley, focusing on sectors such as biotechnology, medical devices, advanced materials, and information technology. Its investment portfolio included several life science companies, such as Linden Bioscience, Invenio Imaging, and Omeros. The firm leveraged its extensive networks in Southeast Asia, Greater China, and the United States to provide strategic guidance and capital to its portfolio companies. 3V SourceOne Capital is currently inactive, having been officially struck off in 2024.

Industry: Investors

Beyond the preview

Go deeper on 3V SourceOne Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3V SourceOne Capital.

Explore the full profile